UroXatral
/
UroXatral is an alpha-1 adrenergic antagonist used to treat the symptoms of benign prostatic hyperplasia (BPH) in men. It is administered as an oral tablet and is available by prescription only. Patients are advised to use caution as UroXatral may cause dizziness or fainting, particularly after the first dose, and should not be used in patients with severe hepatic impairment.
FAQs about UroXatral
How long does it take to work?
The onset of action for UroXatral (alfuzosin) is typically within a few days, but individual responses may vary. Patients are advised to consult their prescriber for specific expectations regarding treatment outcomes.
What should I do if I miss a dose?
If you miss a dose of UroXatral, take it as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and resume your regular dosing schedule. Do not take two doses at the same time.
Can I take UroXatral while pregnant or breastfeeding?
The use of UroXatral during pregnancy is not recommended unless clearly needed, as there are no adequate studies in pregnant women. It is also not known if alfuzosin is excreted in human milk, so caution is advised when administering to breastfeeding mothers.
Can I stop taking UroXatral suddenly?
Patients are advised not to stop taking UroXatral suddenly without consulting their prescriber, as abrupt discontinuation may lead to a return of symptoms. It is important to follow your prescriber\
25
commonly-prescribed
medication.